Sangamo Reports Net Loss of $7.4 MIL for 2nd QTR 2008 (Financial Report)
Biotech Financial Reports 2008, Sept 1, 15, 9
-
- $5.99
-
- $5.99
Publisher Description
Sangamo BioSciences, Inc. (NASDAQ:SGMO), Richmond, Calif., has reported second quarter 2008 financial results and accomplishments. For the second quarter ended June 30, 2008, Sangamo reported a consolidated net loss of $7.4 million, or $0.18 per share, compared to a net loss of $5.2 million, or $0.15 per share, for the same period in 2007. As of June 30, 2008, the company had cash, cash equivalents and investments of $64.3 million.
GENRE
Business & Personal Finance
RELEASED
2008
September 1
LANGUAGE
EN
English
LENGTH
6
Pages
PUBLISHER
Worldwide Videotex
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
61
KB
More Books Like This
Enzo Biochem Reports 3rd Qtr 2010 Gross Profit up 11% (Company Overview) (Financial Report)
2010
Seattle Genetics Reports on 2008 and 2009 Outlook
2009
ENZO Biochem Reports Record Fiscal 2009 First Quarter Revenue (Financial Report)
2009
Vertex Reports First Qtr 2010 Total Revenues OF $22.4 Million (Financial Report)
2010
Response Biomedical Corporation Announces Second Quarter Results
2010
Magnachip Reports Strong Second Quarter 2010Financial Results
2010
More Books by Biotech Financial Reports
Ing Renault F1 Team Chooses Appro Xtreme-X Supercomputer
2008
Avigen Reports Net Loss of $7.3 MIL for 2nd QTR 2008 (Financial Report)
2008
Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report)
2008
Gilead Sciences Reports 2nd QTR Revenues of $1.28 Billion (Financial Report)
2008
Curis Reports First QTR 2008 Net Loss of $3.4 Million (Financial Report)
2008
Baxter Achieves Record Sales and Earnings for Full-Year 2007
2008